AR215629A1 - Procedimiento para la preparacion de derivados 6-halonicotinoilicos de 6-(m-aminofenil)-2,3,5,6-tetrahidroimidazo(2,1-b)tiazol(m-aminotetramisol) - Google Patents

Procedimiento para la preparacion de derivados 6-halonicotinoilicos de 6-(m-aminofenil)-2,3,5,6-tetrahidroimidazo(2,1-b)tiazol(m-aminotetramisol)

Info

Publication number
AR215629A1
AR215629A1 AR267385A AR26738577A AR215629A1 AR 215629 A1 AR215629 A1 AR 215629A1 AR 267385 A AR267385 A AR 267385A AR 26738577 A AR26738577 A AR 26738577A AR 215629 A1 AR215629 A1 AR 215629A1
Authority
AR
Argentina
Prior art keywords
tetrahidroimidazo
halonicotinoilic
aminotetramisol
aminophenil
thiazol
Prior art date
Application number
AR267385A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR215629A1 publication Critical patent/AR215629A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR267385A 1976-05-01 1977-04-28 Procedimiento para la preparacion de derivados 6-halonicotinoilicos de 6-(m-aminofenil)-2,3,5,6-tetrahidroimidazo(2,1-b)tiazol(m-aminotetramisol) AR215629A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17883/76A GB1516938A (en) 1976-05-01 1976-05-01 Halopyridylamides of m-aminotetramisole and their use as anthelmintics

Publications (1)

Publication Number Publication Date
AR215629A1 true AR215629A1 (es) 1979-10-31

Family

ID=10102899

Family Applications (1)

Application Number Title Priority Date Filing Date
AR267385A AR215629A1 (es) 1976-05-01 1977-04-28 Procedimiento para la preparacion de derivados 6-halonicotinoilicos de 6-(m-aminofenil)-2,3,5,6-tetrahidroimidazo(2,1-b)tiazol(m-aminotetramisol)

Country Status (24)

Country Link
US (1) US4112102A (es)
JP (1) JPS52133998A (es)
AR (1) AR215629A1 (es)
AT (1) AT355572B (es)
BE (1) BE854073A (es)
CA (1) CA1067082A (es)
CH (1) CH620218A5 (es)
CS (1) CS189598B2 (es)
DD (1) DD130149A5 (es)
DE (1) DE2718976A1 (es)
DK (1) DK142583B (es)
ES (1) ES458249A1 (es)
FI (1) FI60712C (es)
FR (1) FR2349592A1 (es)
GB (1) GB1516938A (es)
IE (1) IE45140B1 (es)
IL (1) IL51875A0 (es)
LU (1) LU77233A1 (es)
NL (1) NL162389C (es)
NZ (1) NZ183876A (es)
PH (1) PH11989A (es)
PT (1) PT66491B (es)
SE (1) SE432423B (es)
YU (1) YU102377A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041322A1 (en) 1980-05-30 1981-12-09 Beecham Group Plc m-Pyrazolylamido tetramisole derivatives, compositions thereof, processes for production of such compounds and compositions and their use in treating helminthiasis
WO2018231704A1 (en) * 2017-06-12 2018-12-20 Dow Agrosciences, Llc 6-bromonicotinamide and processes of preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (es) * 1964-05-11
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
GB1365515A (en) * 1971-09-03 1974-09-04 American Cyanamid Co 6-tetrahydro imidazol/2 1-b/thiazoles
CA982136A (en) * 1971-09-07 1976-01-20 Larry D. Spicer 6-(aminophenyl)-2,3,5,6-tetrahydro(2,1-b)thiazoles
JPS4839492A (es) * 1971-09-23 1973-06-09
CH556871A (de) * 1971-09-24 1974-12-13 American Cyanamid Co Verfahren zur herstellung von substituierten 6-phenylimidazo (2,1-b)thiazolen.
BE773062R (fr) * 1971-09-24 1972-03-24 American Cyanamid Co Nouveaux phenyltetrahydrothiazoles, leur preparation et leurs utilisations therapeutiques

Also Published As

Publication number Publication date
DE2718976A1 (de) 1977-11-17
FI771362A (es) 1977-11-02
NL7704662A (nl) 1977-11-03
DD130149A5 (de) 1978-03-08
IE45140B1 (en) 1982-06-30
ATA305677A (de) 1979-08-15
FI60712C (fi) 1982-03-10
SE7703553L (sv) 1977-11-02
US4112102A (en) 1978-09-05
NL162389B (nl) 1979-12-17
JPS5713554B2 (es) 1982-03-17
AT355572B (de) 1980-03-10
NL162389C (nl) 1980-05-16
SE432423B (sv) 1984-04-02
GB1516938A (en) 1978-07-05
PT66491B (en) 1978-09-29
IL51875A0 (en) 1977-06-30
YU102377A (en) 1982-06-30
CH620218A5 (es) 1980-11-14
FR2349592A1 (fr) 1977-11-25
ES458249A1 (es) 1978-06-01
LU77233A1 (es) 1977-08-18
DK186877A (es) 1977-11-02
PH11989A (en) 1978-10-05
CA1067082A (en) 1979-11-27
DK142583B (da) 1980-11-24
PT66491A (en) 1977-05-01
JPS52133998A (en) 1977-11-09
DK142583C (es) 1981-07-27
CS189598B2 (en) 1979-04-30
FR2349592B1 (es) 1980-09-19
IE45140L (en) 1977-11-01
NZ183876A (en) 1979-03-16
BE854073A (fr) 1977-10-28
AU2437377A (en) 1977-09-29
FI60712B (fi) 1981-11-30

Similar Documents

Publication Publication Date Title
AR219560A1 (es) Procedimiento para la preparacion de derivados de 5,5-dimetil-hidantoina
ES508618A0 (es) Procedimiento para la preparacion de derivados de la quino- lina.
AR221851A1 (es) Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
RO71301A (ro) Procedeu de preparare de derivati de 2,3-dihidro-imidazo(2,1-b)tiazoli
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
ES479490A0 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
AR220675A1 (es) Procedimiento para la preparacion de derivados sustituidos de pirido(1,2-a)pirimidinas
AR224381A1 (es) Procedimiento para la elaboracion de 1,3-diazaciclopent-2-eno(2,1-b)(1-tia-3-aza-cicloalcanos)
AR225666A1 (es) Procedimiento para la produccion de derivados para la produccion de derivados de 1-alquil-1-alquenil,alcoxi o alquil-3-5-alquil,fenil o halo-3-isoxazolilourea
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
AR217688A1 (es) Procedimiento para la preparacion de derivados de trans-2-sustituido-5-aril-2,3,4,4a,5,9b-hexahidro-1h-pirido(4,3-b)-indol
AR217426A1 (es) Procedimiento para la preparacion de nuevos derivados de 7-(3-indoliloxi,naftiloxi o fenoxi-2-hidroxi-propilamino-alquil)-teofilina
ES494291A0 (es) Procedimiento para la preparacion de derivados diazoicos.
ES497530A0 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ES489184A0 (es) Procedimiento para la produccion de derivados de feobromina.
AR220120A1 (es) Procedimiento para la fabricacion de derivados de 1-alquil-4-(n-acetil)amino-tetrahidro-1,3,5-triazol-2,6-diona
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
AR225415A1 (es) Procedimiento para la obtencion de nuevos derivados de pirido(2,1-b)quinazolina
ES493931A0 (es) Procedimiento de preparacion de nuevos derivados de la 3,4,5-trimetoxi-cinamoil-piperazina
ES501213A0 (es) Procedimiento para la preparacion de derivados de 2,3,4,5- tetrahidro-1-benzoxepin-3,5-diona
MX6009E (es) Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas
ES513392A0 (es) Procedimiento para la obtencion de derivados de 2-amino-piridina sustituidos.
AR230835A1 (es) Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido
ES494211A0 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.